Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised.
Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company. We are seeking a Director, Human Resources Business Partner, DACH to serve as the strategic HR partner for Germany, Austria, and Switzerland, supporting the company’s first EU commercial launch planned for 2026–2027.
Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised.
Cytokinetics